Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CDEX 8K Filing
http://www.secinfo.com/d1526c.vj.htm
I have thanked MP...But I would also like to thank him publically for, IMOP, a job well done. A lesser man would have given up and thrown in the towel..
I have ALWAYS said, and I still say..Malcolm Philips is a man of integrity. I thank him for sticking to the job and bringing us this far..
Thanks, Malcolm...
Godspeed to you and your family.
Talk about the right place at the right time.
Compliments of butterflyfl
Big Big Bucks and it still has to be checked
Feb 2004
Hospitals take aim at errors
Millions spent to avoid medication mistakes
By Tim Bonfield
The Cincinnati Enquirer
At Bethesda North Hospital, nurses are training to use a $3.8 million system that runs IV medications through a machine that looks like a bank of oversized calculators.
Rhonda Wilson, RN, a nurse manager in the Telemetry unit at Good Samaritan Hospital, checks out the Medley Medication Safety System, an intravenous delivery system for medications and fluids.
(Gary Landers photo)
At Cincinnati Children's Hospital Medical Center, a $640,000 medication mixing robot will be installed this summer to automatically prepare as many as 600 injections a day.
And this fall at University and Christ hospitals, a three-year program begins to encourage doctors to order medications via computer rather than handwritten slips of paper.
These and other hospitals in Greater Cincinnati are pumping millions of dollars this year into ways to reduce the number of deaths, injuries and treatment problems that can result from medication errors.
"In every hospital, medication errors occur every day," says Sandi King, manager of clinical safety for the TriHealth hospital group.
"Human errors occur because we are human. We get tired. We have too many irons in the fire."
Although no local statistics are available, an estimated 44,000 to 98,000 people a year die from medical errors of all kinds in hospitals nationwide. Of those, medication errors account for about 7,000 deaths a year, according to the Institute of Medicine.
Medication errors also can lead to disabilities, lawsuits and uncounted millions spent on longer hospital stays and emergency treatments.
Since the late 1990s, regulatory agencies, consumers and other interest groups have demanded that hospitals do more to reduce medication errors. In Cincinnati, that pressure has resulted in a wave of spending on new technology.
With so many patients using so many medications, it is easy to imagine that mistakes will be made.
The doctor might misspell the medication. The pharmacist might misread the doctor's instructions. The nurse might punch one too many zeros into the pump that sets the drip rate.
Patients at TriHealth hospitals use more than 550,000 IV bags of medication a year. To replace its lower-tech infusion pumps, the hospital group has turned to San Diego-based Alaris Medical Systems.
The company is one of a handful nationwide that make "smart" infusion pumps that can alert staff if a prescribed dose falls outside pre-programmed high and low dose ranges. Software tracking systems also can send "near miss" reports to hospital administrators.
So TriHealth plans to replace about 625 infusion pumps with the new Alaris system. Not only does the system sound alarms, it can keep track of near-misses for quality improvement reports.
A new approach
Before automation, hospitals relied on a "Swiss cheese" approach to avoid medication errors, says Jack Horn, director of pharmacy for Cincinnati Children's.
While no single human is perfect, errors can be reduced by having multiple people checking that the right medication dose is going to the right patient. Doctors, pharmacists, nurses, technicians, even patients and family members have roles to play - much like layers of Swiss cheese with holes in different places.
"But eventually, the holes line up and an error gets through," Horn said.
The IntelliFill robot system to be used at Children's Hospital is made by Florida-based ForHealth Technologies Inc.
The device is about the size of three refrigerators strapped together and can fill 300 syringes an hour - each with a custom dose and a bar code label routing it to a particular patient.
Such a robot is especially useful in a pediatric hospital because doses have to be adjusted by a patient's weight.
A paperless future?
The Health Alliance of Greater Cincinnati is talking with two vendors about replacing its IV infusion pumps and is considering buying a medication mixing robot, said Dr. Marianne Ivey, director of pharmacy services.
But the most far-reaching project for the Health Alliance will be installing a computer order-entry system to replace handwritten prescription orders from doctors.
The project is expected to take three years to fully install. Small pilot projects involving parts of University and Christ hospitals will begin this fall, Ivey said.
The move would make the Health Alliance the first adult hospital in town to follow Children's Hospital, which launched a similar program in 2002.
Mercy Health Partners plans to spend $25 million in the next five years on error-reducing technology, including about $10 million to install a computer order entry system by the end of 2005, says Jana Deen, regional vice president of patient safety support.
Mercy Health Partners does not plan to buy robotic systems, but smaller projects, including computerized pill dispensing systems, already have been started at all five area Mercy hospitals. Upgrades to infusion pumps also are planned.
"We're already seeing some improvements. We expect to see more," Deen said.
Small hospital challenges
Error-reducing technology ranges widely in Greater Cincinnati. Smaller hospitals with fewer patients have less ability to spread the costs of technology buys.
"We're too small for robots and those kinds of things. But there are a lot of other things you can do to reduce medication errors," says Sylvia Burkey, chief operating officer for McCullough-Hyde Memorial Hospital in Oxford.
For example, the hospital has spent tens of thousands on upgraded infusion pumps and an automated pill-dispensing system.
But Burkey said it could be years before small hospitals can afford to invest in computerized ordering systems.
"Those kinds of things cost a lot of money. And Medicare doesn't increase our reimbursement rates for doing these things," Burkey said.
So instead of relying so much on hardware, smaller hospitals are looking at ways to improve training and organization for staff.
"It's as much about organizational review as about buying a particular piece of technology," she said.
Machines make mistakes too
Anyone familiar with software bugs and power outages knows that machines make mistakes, too.
At Children's Hospital, pharmacy staff already run daily validation tests on medication systems. They expect to make frequent checks on the new syringe-mixing robot as well.
So even though the new machines will help reduce human error, Horn says, hospitals will always need people to check the machines.
The impact of medication errors
• 44,000 to 98,000 people a year die from medical errors in hospitals nationwide.
• 7,000 of those deaths are blamed on medication errors.
• $37.6 billion is spent annually because of medical errors.
• Adverse reactions to drugs injure more than 770,000 people each year in hospitals.
• Patients who have adverse drug reactions were hospitalized an average of 8 to 12 days longer than similar patients.
• Between 28 percent and 95 percent of adverse reactions can be prevented through computerized monitoring systems.
• Computerized medication order entry may prevent an estimated 84 percent of dose, frequency, and route errors.
--Sources: The Institute of Medicine and the Agency for Healthcare Research and Quality, an arm of the U.S. Department of Health and Human Services
---
New Valimed board on IHub.
http://www.investorshub.com/boards/board.asp?board_id=4938
Happy New Year to the Cdex long and faithful. IMHO Valimed/Cdex will rock in 2006. Yes, it is long awaited. Yes, there are those that don't want it to happen. Yes, there is a group of non shareholders, who are bashing the heck out of this stock for years. Yes, we will be able to laugh in there faces. Yes, there are a few shareholders who sold there shares because of the constant bashing. In my eyes the bashers are criminals. There intent to damage Cdex, and hurt shareholders has been very obvious. The SEC has been notified.
On a positive note, we have Cdex and they don't. Unless they are buying CEXI shares? We know we have many Valimed products, and are on the path to success along with Baxa. What will we have with Homeland Security? With Mr. Griffin, I believe we will have something? All IMHO of course.
What PPS will we achieve? I haven't a clue. Will we have a forward spilt? I haven't a clue. Will we end up on a different exchange? I haven't a clue. Will the next few quarterlies show significant revenue? I haven't a clue. We shall see! I believe we are on to something that is going to be very successful.
EATING like that it's no wonder you can't play tennis anymore!!!LOL
Merry Christmas to all.
INET6
Viking65: I have invited myself to breakfast,thank you, expect me about 10:00am. What a great time we will all have, lol.
Have a very Merry Chirstmas and a Happy New Year to all.
We might sleep in a little later than usual Christmas morning, after attending Midnight Mass, the next morning we have our annual Christmas Breakfast. Merry Christmas to all.
We are having.....
Light & Fluffy Buttermilk & Blueberry Pancakes Slathered in Butter & Real Maple Syrup...
Fresh Country Sausage Patties & Links...
Hash Browned Potatoes with Onions & Green Peppers...
Plenty of Eggs... Fried, Scrambled & Over Easy...
Hot Buttered Toast...
Ice Cold Fresh Squeezed Orange Juice...
Belgian Waffles with your Favorite Fruit Topping...
Plenty of Toast, Sweet Breads, Jams & Jellies...
Thick Sliced Bacon, Fried to Perfection...
Hot Country Biscuits, Topped With Sausage Gravy...
Mouth Watering Homemade Fried Chicken...
Golden Brown Home Fried Potatoes Fried in Sweet Creamery Butter...
Hot Steamy Grits for you Southern folk....
Cinnamon Raisin Toast, covered in Sweet Butter...
Delicious Virginia Ham, Sliced Thick...Tender & Sweet
My Special Homemade Oatmeal with Apples & Nuts...
And this is all topped off with a Bottomless Cup Of Piping Hot, Fresh Brewed Coffee....with Fresh Cream & Sugar, if you like...
From : Malcolm H. Philips, Jr. <mphilips@cdex-inc.com>
Sent : Thursday, December 22, 2005 9:24 AM
To : xxx xxxxxxxx
Subject : RE: Thanks
| | | Inbox
Mr. xxxx: Thanks for the note. We believe that God has guided our efforts
and blessed what we are doing. I personally have said countless times that
in my life I push forward making countless mistakes, but with the right
heart, and God takes it all and makes it come out positive for Him. It is
not because we are smart, good talkers, savey business types, etc, that
things have worked out for the Company; it is because of His hand and we are
humbled and honored by that. God Bless and Merry Christmas. BTW, have you
read "The Purpose Driven Life" -- Good book to consider. Thanks again. CDEX
Management
-----Original Message-----
From:xxxx
Sent: Thursday, December 22, 2005 8:42 AM
To: mphilips@cdex-inc.com
Subject: Thanks
Dear Sir:
I would like to thank you all for your dillegent effort and the remarkable achievements for the year ending. I am hopeful and excited for the new year
and the continued success of CDEX.
I wish you all a very Merry Chirstmas and a Happy New Year.
Best regards
xxx
The Technology Development Company
©Copyright CDEX, Inc.
All Rights Reserved
CAREERS
We are always looking for bright, hard working, talented individuals with strong potential to contribute to the goals of CDEX by joining our team. Lab Technician / Pharmacy Admixture Tech Join an exciting tech company.
CDEX Inc Technical Operations facility located in Tucson, Arizona invites applications for employment from experienced Laboratory Technicians and Pharmacy Admixture Technicians. Initially to support extended development of our current Valimed pharmacy application, with subsequent research efforts in evaluation of this exciting technology to other applications including physiologic Point-of-Care testing products.
Training and experience in biology/biological, medical, or pharmacy/pharmacology research laboratory applications preferred and/or Pharmacy Admixture experience. Training in the proper handling of human derived samples is a must. Please contact techjobs@cdex-inc.com There are no other job openings at this time, however, for future consideration you may email your resume to techjobs@cdex-inc.com
Great DD by captnmike:
By: capnmike
21 Dec 2005, 08:26 PM EST
Msg. 23242 of 23246
(This msg. is a reply to 23240 by dw88in.)
Jump to msg. #
dw88in, is this the position you are referring to in your post?
http://regionalhelpwanted.com/Search/detail.cfm?SN=18&ID=14422
Job Title: Lab Technician / Pharmacy Admixture Tech
Position Available: Immediately.
Job Location: Tucson
Reply To: CDEX Inc
Email: Respond via email
Web: http://www.CDEX-INC.com
Job Category: Healthcare: Pharmacy
Bio/Life Science
Healthcare: Laboratory/Pathology
Lab Technician / Pharmacy Admixture Tech
Join an exciting tech company
CDEX Inc Technical Operations facility located in Tucson, Arizona invites applications for employment from experienced Laboratory Technicians and Pharmacy Admixture Technicians. Initially to support extended development of our current Valimed pharmacy application, with subsequent research efforts in evaluation of this exciting technology to other applications including physiologic Point-of-Care testing products.
Training and experience in biology / biological, medical, or pharmacy / pharmacology research laboratory applications preferred and/or Pharmacy Admixture experience. Training in proper handling of human derived samples a must.
Additional information about our company can be found at www.CDEX-INC.com
Please submit resumes to techjobs@cdex-inc.com
CDEX Inc
Job Location: Tucson
Available Immediately
Posted: 12/13/05
Ok. Here's the link.
http://regionalhelpwanted.com/Search/index.cfm?SN=18
Lab Technician / Pharmacy Admixture Tech Posted: 12/13/05
Blackdog6: Yes I understand I google searched it with all key words cdex tucson add application employment ect. ect. But could not find the add. Just thought you may remember where you found the add. The link would confirm these new positions at cdex and that is a big deal to me. I think these are new positions but not sure I'll try another search when time will alow. Thanks.
No. It's too much trouble to go find it. I had to scroll through a long list of job openings and I just stumbled across it while looking for something else. I believe I got to it through a link to a Tucson job listing site through a local radio station.
It's no big deal. Just a job opening.
If you are that interested try some Google searches for jobs in Tucson - CDEX.
Woof.
Blackdog6: Could you post the link for that jobseeking site in Tucson Thanks.
I do not know about the post on the website, but as I recall the source of my post was through a local Tucson jobseeking site and it was within the last week.
Woof.
Are these new openings for cdex or have they been listed for a while?
http://www.cdex-inc.com/careers.html
The Technology Development Company
©Copyright CDEX, Inc.
All Rights Reserved
CAREERS
We are always looking for bright, hard working, talented individuals with strong potential to contribute to the goals of CDEX by joining our team. Lab Technician / Pharmacy Admixture Tech Join an exciting tech company.
CDEX Inc Technical Operations facility located in Tucson, Arizona invites applications for employment from experienced Laboratory Technicians and Pharmacy Admixture Technicians. Initially to support extended development of our current Valimed pharmacy application, with subsequent research efforts in evaluation of this exciting technology to other applications including physiologic Point-of-Care testing products.
Training and experience in biology/biological, medical, or pharmacy/pharmacology research laboratory applications preferred and/or Pharmacy Admixture experience. Training in the proper handling of human derived samples is a must. Please contact techjobs@cdex-inc.com There are no other job openings at this time, however, for future consideration you may email your resume to techjobs@cdex-inc.com
Blackdog6: Great find and thanks for sharing eom.
Just came across this CDEX Help Wanted Ad in Tucson
Lab Technician / Pharmacy Admixture Tech
Join an exciting tech company
CDEX Inc Technical Operations facility located in Tucson, Arizona invites applications for employment from experienced Laboratory Technicians and Pharmacy Admixture Technicians. Initially to support extended development of our current Valimed pharmacy application, with subsequent research efforts in evaluation of this exciting technology to other applications including physiologic Point-of-Care testing products.
Training and experience in biology / biological, medical, or pharmacy / pharmacology research laboratory applications preferred and/or Pharmacy Admixture experience. Training in proper handling of human derived samples a must.
Additional information about our company can be found at www.CDEX-INC.com
Please submit resumes to techjobs@cdex-inc.com
CDEX Inc
Location: Tucson
Available Immediately
Posted: 12/13/05
Right link for bashers http://www.messageboardfools.com/bashers.htm
More from ASHP event Part 2. Thanks Capnmike.
Trying to get through all my notes in a quick pass... here is some more that should be of interest:
= = = = = = =
I don't want to divulge individual names or organizations in this paragraph because I haven't yet confirmed it is okay, but I can share that a hospital/researcher working with ValiMed systems interviewed at another very well known organization and they asked this person if they would be interested in continuing their ValiMed work if they joined this organization. It was explained to me that the pediatric hospital network is an extremely tight network, and nothing this significant goes on without the entire pediatric hospital community taking note.
= = = = = = =
One of the ValiMed devices had what I would describe as a rolling slide show in the upper corner with various hospital names/logos/pics. Some of these were new to me, and it was confirmed they have ValiMed in place. Others at the event saw and noted this as well, so even if I can't locate the list I wrote, I'm confident more info will come.
= = = = = = =
At one point, a woman came to the ValiMed booth when it was extremely busy. This woman began showing the group she was with how the ValiMed systems work. As we all might guess, this did catch the eye of our ValiMed team, so they asked if they could be of assistance. The woman replied, "Oh no. I'm just showing them how ValiMed works."
( one just has to appreciate the odd pause here.... )
Looking at the badge, it turns out she is with one of our current ValiMed hospitals, and I'm 95+ percent sure she indicated they had just ordered more devices.
= = = = = = =
In very large hospitals, stat med orders are a big big issue. (refer back to my note regarding Hanna's comment when validating the dopamine drip !)
= = = = = = =
The following sentence is in my notepad, but I must say I'm sorry I didn't add more regarding the specific context!!! You might agree, it tends to help get a perspective on the type of content and exciting "light bulb" moments that were going on; from my notebook: "ICU DRIPS = BROADEN THE FUTURE"
I didn't even note who said that!
= = = = = = =
I personally watched one person from a famous university go from device to device, then begin discussions, then begin multiple demonstrations.
= = = = = = =
I personally watched a children's hospital (a northern location) decision maker speak with Carlos at length on Tuesday, with the full suite of demos.
= = = = = = =
Seeing the ValiMed application on the IV pole (and seeing the other device that actually scanned the IV bags) really got me thinking. I asked Dr. Marsteller if those applications would require additional review by the FDA. What I remember is that Dr. Marsteller seemed very much on top of that subject, and I think he explained there are something like three-levels or general category of FDA approval for medical devices. The applications where the light source is fluorescing a small sample or waste are the ones that are already in use in multiple hospitals. The applications I asked about might be the next level up. I can tell you all one thing for sure - that IV pole application has MANY folk excited!
= = = = = = =
I have had very high hopes for a long time, and what I saw and learned simply eclipses my highest hopes. We are MUCH MUCH farther along than I had dared to hope. I can't seem to find the exact wording here, but in 6 years I have never felt this comfortable (and excited at the same time). It is going to be wonderful. I know that it will be wonderful because it already is wonderful.
= = = = = = =
In some follow-up reports I hope to provide some detail and my own perspective as to why each of the people I met have a well-earned WOW. Folks, I told the three Baxa reps yesterday that I had goose bumps again after we discussed what is happening. Each and every day there were moments where I had goose bumps, and each and every day I had moments where I thought my head was going to explode (which has nothing to do with the exploding head feeling hours after my first single-malt scotch experience LOL!
By: capnmike REPORT on the ASHP Event...
08 Dec 2005, 11:51 AM EST
Msg. 22831 of 22830
Jump to msg. #
ASHP event - initial report
PEOPLE
I met Mr. Malcolm Philips and enjoyed multiple meaningful conversations that continue to have an extremely powerful and positive impact on my outlook, expectations, and overall perspective. There is far more here than he simply building our CDEX team and initial partnerships, but focus on that one area for a moment. The importance of this man’s stewardship cannot be overstated in my ‘very considered’ opinion. In no particular order or sequence…
I met and had meaningful discussions with:
Mr. Tim Shriver. <---- Wow!
Mr. Carlos Alvarez. <---- Wow!
Mr. Jerry Blair. <---- Wow!
a number of savvy investors. <---- Wow!
Dr. Larry Marstellar. <---- Wow!
Mr. Carey Starzinger. <---- Wow!
Mr. George Dials. <---- Wow!
Ms. Hanna Phan, Pharm D, Univ of Mich. <---- Wow!
Mr. Larry Grzebinski, Gen Mgr, Canadian Distribution Centre, BAXA <---- Wow!
Mr. Brad Wills. <---- Wow!
I met and had a brief but VERY meaningful discussion with Mr. Eric Kastango. <---- Wow!
I met (again) Dr. Wade M. Poteet. <---- Wow!
I met and had meaningful discussions with Shaun Priest. <---- Wow!
I met and had meaningful discussions with ValiMed pharmacist Steve Kirsch <---- Wow!
I met and had meaningful discussions with Mr. James Griffin. <---- Wow!
I met and had meaningful discussions with a number of BAXA representatives. <---- Wow!
I met and had lengthy meaningful discussions with an individual (management) for a large and impressive GPO (group purchasing org) during my flight. Contact and other information was swapped and appropriately forwarded. <---- Wow!
I met and had meaningful discussions with a medical consultant (impressive background – eg: designed clean rooms, plus other USP 797-related work with well recognized hospital systems). This individual was responsible for managing another booth and asked me to please bring him the ValiMed liturature and contact info, which I did. He also provided his business card, which is now in good hands at ValiMed.
The conversation above was conducted while we stood together watching BAXA’s amazing 50 minute training video by University of Utah’s James Jorgenson, MS, RPh, FASHP. (yes, the ValiMed client!) <---- Wow!
Observations
ValiMed / CDEX is providing multiple devices for demonstrations. I have photos and short video clips stored on my digital camera. One device is mounted on an IV pole exactly as a typical IV pump would be mounted, and is demonstrating the capability of monitoring the contents being transported via the tubing. One device is designed for validation of a single target – it is very small and very fast, and very straightforward (the user interface is extremely simple – no screen/menu). The ValiMed device we’ve all seen in the University of Michigan video is there too of course, and I was pleased to see how the design supports various medication forms (one mount provides validation of syringe contents, another supports validation of medication vials, etc). Yet another device validates an entire IV bag.
After 3-days at the event, it became clear that people tended to come in surges or waves, then a brief quiet period might present itself for team members to literally catch their breath, and then more people would appear. The individuals visiting the ValiMed booth were hospital pharmacy directors, executives with large hospital systems, doctors being sponsored by other ASHP-related groups, etc --- DECISION MAKERS ALL!!
At one point I was watching the action in the ValiMed booth from a neighboring booth, and a gentleman approached our booth. He was an M.D. from the University of Maryland, and announced they had orders in already and wanted to see more. What was even more impressive to me? Dr. Larry Marstellar was right there in our booth and was able to discuss and demonstrate in a doctor-to-doctor capacity. When pharmacy directors came to the ValiMed booth for demonstration and discussion, we are able to demonstrate in a pharmacist-to-pharmacist mode (both Jerry Blair + Steve Kirsch). I kid you not when I tell you all it became a game with me…. Someone would approach the ValiMed booth, be greeted by say Carlos, or Shawn, etc. A brief discussion would be followed by a demo and their lips would purse and I would think “here it comes!!!” and the word “WOW” would role off of their lips.
If interested parties come to the ValiMed booth, they received a colorful card that says “Bring this card to the Baxa booth, #2221 to receive a free gift and register to win an iPod video. If interested parties come to the BAXA booth before they see the ValiMed booth, they observe a very large booth with a plethora of knowledgeable BAXA reps., and a ValiMed banner right in the center of the action. Color glossies show the 5 “Rs” (Right Patient, Right Time, Right Route, Right Drug, Right Dose) with a question mark next to the Right Drug? Right Dose? Bold letters ask (overtop a color photo of gloved hand with syringe) “Is 3 out of 5 GOOD ENOUGH FOR YOU? Your patients rely on you. Do your medication safety practices ensure their basic rights? ValiMed Medication Validation System – Validating Medication Safety One Dose at a Time. The flip side of the glossy hand-out has color photo of a ValiMed device, graphics and text similar to our ValiMed web site, and: Now distributed exclusively by Baxa Corporation, the ValiMed System….” “FIND OUT MORE ABOUT HOW YOUR FACILITY CAN VALIDATE SAFETY. Contact Baxa Corporation at 800-567-2292 or send an e-mail to marketing@baxa.com
When I met Mr. Eric Kastango, he said he believed the BAXA-VALIMED partnership was PERFECT. He said more too!
I attended the first Univ of Michigan poster session and have a short video clip. Hanna Phan was very helpful and informative. The first two med errors that were identified are mentioned on their poster, which states that “at least” two errors have been detected. She shared that they involved Vancomycin. She also verified that just last week a morphine drip concentration error was detected. And consider this…. Hanna said one child was on a dopamine drip and the doctors and nurses were not seeing expected results. They began wondering if the IV was the exact drug and concentration that was ordered, so started to do what most hospitals do…. Send it to the lab for a stat analysis. At that point, they realized they had this particular dopamine signature available in their ValiMed device (keep in mind… a signature is the combination of 1) drug, 2) concentration, and 3) diluent), so instead of the slow and expensive process involved with a stat-lab order, they got what they needed very very quickly and very very cheaply right on the spot!! Yes – the dopamine was exactly what the doctor had ordered, so the lack of expected results was clearly related to something other than a medication error. WOW~!
Folks – can you say “lab in a box?”
Also – we discussed their bullet point documenting that not all drugs fluoresce. From my limited layman research (I am not a pharmacist and I am not a fluorescence expert), I believe it would be accurate to say somewhere around 80 or 90 percent of the potential target drugs will fluoresce. This even got me thinking about what I had learned about the University of Maryland’s work in IR, so even if there is a highly desirable target drug that does not fluoresce in the UV range, I bet many of those would fluoresce in the infrared. For additional research – read about the University of Maryland IR fluorescence work and read about CDEX team infrared expertise and accomplishments in the IR range….. very comforting to me that we have so much depth!!!
Three more Baxa reps arrived from Denver yesterday morning and I had the opportunity to meet with them before the show opened. They are SOOO EXCITED about ValiMED!!!
BAXA is also providing color fold-over handouts with “The right equipment…” on the front, and USP 797 info inside. Refer to www.baxa.com/USP797
I asked a BAXA rep if they knew when the ValiMed equipment would appear on the Baxa web site and the Baxa Product Catalog, etc. She said she should could not say for sure, but was confident it would not take too long. She added that Marian is absolutely amazing.
Folks, in my view, BAXA’s Univ of Utah video with CE credit available, the BAXA product catalog, the presentations, the ValiMed banner --- ALL ARE 100% the best professional product one might hope for!
The lights are flickered at the end of the day to signal ASHP attendees and sponsors the day is almost over. At that time one day I saw (first hand) a gentleman approach BAXA’s Larry Grzebinski who happened to be at our ValiMed booth at the time. After a brief discussion, this man handed Larry a credit card to buy ValiMed equipment. I couldn’t hear everything that transpired (and I even thought perhaps it was a friend of Mr. Grzebinski being funny), but I am convinced it was ligit… the guy wanted to buy on the spot. My best guess is that Larry explained it didn’t work like that (you know, it is an ordering process, etc). The point is…. I am completely confident we are going to see revenue figures in the relatively near future that will be very interesting. I could not be more impressed with our technology’s advances, our team, and our partners – I feel impressive revenue will come of this and lives will be saved. Please allow me to repeat…
I could not be more impressed with our technology’s advances, our team, and our partners – I feel impressive revenue will come of this and lives will be saved.
Any and all that spoke with our CDEX COO, Jim Griffin, probably learned more about his business views. In a nutshell, he stresses that he does not pursue application of resources for incremental gains and incremental improvements on existing technology. Mr. Griffin appears to bring a highly disciplined business perspective whereby an analysis is performed, and once the market is identified, every swing is for a home run.
I firmly believe we are all in for a real treat…. I firmly believe we are going to learn about a business plan or plans, with the who/what/when/where/how/why documented for our review, and I will not be surprised if it is done in a manner that not only allows shareholder questions and debate, but also might actually expect and thrive upon said input!
To the entire CDEX team - - A very special and sincere “Thank You”
CapnMike
Todays New Google Alert on CDEX-VALIMED
http://www.drugresearcher.com/news/ng.asp?n=64330-baxa-cdex-valimed
Breaking News on Drug Discovery
Previous page : Baxa launches ValiMed system to combat counterfeiting
Print
Baxa launches ValiMed system to combat counterfeiting
05/12/2005- Baxa Corporation launches its medication validation system that validates narcotic returns and identifies counterfeit medications. The system also offers validation of medication to ensure the type and strength of high-risk medications.
Currently the industry of counterfeit pharmaceuticals is causing great concern with the World Health Organisation estimating that 5–8 per cent of worldwide trade in pharmaceuticals is counterfeit.
Many fake pharmaceutical products come from illegal operations with poor controls and may contain ingredients that could be harmful.
One of the failsafe features of the ValiMed system allows the verification of medications in seconds, providing the necessary level of safety in the medication dispensing process.
Its patent-pending technology identifies the strength to validate compounded doses of high-risk medications prior to dispensing.
"The ValiMed Solution offers our customers fluid medication devices that improve operations and increase medication safety," said Greg Baldwin, Baxa Chairman and CEO.
Under an agreement announced in early November, Baxa becomes the distributor of the CDEX ValiMed System for healthcare organisations in the US and Canada, who have expressed interest in utilising this system to meet hospital pharmacy requirements.
"The technology allows pharmacists to ensure the accuracy of compounded solutions, meeting USP 797 and other regulatory requirements," said Malcolm Philips, CDEX CEO and Chairman.
USP 797 and other regulations now require pharmacies to comply with guidelines almost as strict as those required of pharmaceutical manufacturers.
This includes standards in technique, training, and environmental concerns. Most relevantly, these new regulations require that compounded products be tested for accuracy and sterility.
The ValiMed System aims to address an ongoing problem which The Institute of Medicine believes is not decreasing. They estimate that nearly 98,000 Americans die each year from medication errors.
The Institute of Medicine analysts believe the greatest area of vulnerability has proven to be the most difficult to monitor: high alert medications.
Even when clinicians knew their work was being evaluated roughly 5 per cent of all IV admixtures were compounded in error.
The healthcare industry has attempted to respond to the problem, however, the solutions offered are not foolproof.
The best example is an IV, where the only truly effective way to check would be to send a sample to a lab for analysis, adding an unacceptable level of cost and time.
Baxa launches its ValiMed System at the American Society of Health-System Pharmacists Midyear Meeting to be held December 4 – 8, 2005 in Las Vegas, US.
Nice report by pookie:
By: pookie89014
07 Dec 2005, 11:15 PM EST
Msg. 22789 of 22787
Jump to msg. #
Whelp...gulp... we got in there...I can say that Monsooonman maybe..."probably" got out of the cdex booth what dgei and I got...hardly anything more than we know already...
Good thing we have this board and I mean it's "really" good thing that we have this board....
Now...I am going to attempt to relay what I understood but maybe if dgei sees that something is wrong he will come on and correct me.
..You know that Laymen can have a hard time understanding jargon of a field that they are not into...
We got a demo of the machine and how fast it works...perty fast....
ok lets see...the change of color..the Green Machine is now the Baxa Machine..they wanted the color to match their trademark color.
The Machine has the software Capability now of holding about 52?? Signatures and if the hospital needs more they can use 2 machines..If the hospital wanted to validate the flu vaccines that they could add the signatures for it..
The Tech didn't know how much Baxa was selling the Valimed Machine for..and we asked how many different Pharmacy's each hospital had in them and I guess it depended on the size of the hospital...he was unsure...someone else mentioned maybe 3?
I asked about reading blood and he didn't seem to understand any of that..so Bfly I didn't proceed anymore because he really didn't or maybe just dummied up and wouldn't answer that..
We only saw 2 machines there...one in a suitcase and then the one we have all come to recognize... but I know there were a few others there in different stages of development.. we just didn't get introduced to them..
We saw Jim Griffin and Sean Priest but they were both engaged and we found it rude to just stand there..so we moved on...we probably were there for about 15 min or so...(Degi if you have anything to add please do so on your time.
Then we went to the Baxa Booth...we really didn't have much time but we caught a Taped Baxa Commercial "kinda"...they had tv's around the exhibit..it was large...our machine was there..right in the middle.
..anyway back to the Tv's...they interviewed a Nurse head/Boss that was here from the Dallas Children's Hospital...she said they have 3 machines in there now...!
Ok...What else????...Oh yeah.!!..!...We sat in on the UM..presentation on "The use of Spectroscopy to Enhance Safety in IV Compounding".
The room was large and was filled with about 1/3 audience..It really did last about 10 or so minutes...We took a seat...here are some of the notes I took.
Take it..leave it..or.. or tell me if I'm wrong..I will give you my interpretations...
I want everyone to know that I am not Medical Savvy so my notes may not make much sense but as they were talking I was writing my bullet points..that is all I know...
Here Goes....University of Michigan has detected 2 errors since iniating the machines in May and they just found one more since the Document was written making it 3 total as of today.
It does have limitations because not all Drugs Fluoresce drug KCC...doesn't (don't know what drug that is).
Takes cdex one week per signature sample..then Hospital tests it again double check system.
Drug detection times vary a little per different drugs (something about different waves)
Standard concentrations are required.
Something about 9 drugs 32 signatures so far for the UM
Detects 3 entities
Working on a small thermal printed label for Identification
To be placed on drug....Want Technician to be able to free up the nurse..
..I think we just may be working on the labels and working into networking with the Hospital...I think we have the capability of the Doctor and the Pharmacy???at this point?? but I don't think that "at this point" we can follow the Patient..
Now that was what I got from my notes...the session ended quickly..but they asked those that wanted to sit down at different round tables with the various studies? That the persons that conducted these studies will be there for a round table discussions..
Well...we went...Table 12...lol...
We sat down and listened to James Stevenson talk to 2 other Pharmacy Heads about this machine..they were very interested..they knew it was needed and they seemed very interested...they asked questions pertaining to the Notes I took...basically if you can signature your own selection and just inquiring about the much needed tech..He seems to think that Baxa is Great for CDEX...
Dr Marsteller was sitting back on another table listening in...He didn't say to much..he basically stated he wasn't going to be making any forward statements because he knew we were shareholders..but he did answer the questions the other Pharmacist were asking...and was very cordial towards us...he also was a lot younger than I thought he would be.
James Stevenson seems more than thrilled with this machine.
he mentioned his hospital was the first in the world to have this machine..He knows that even the most knowledgeable and experienced Nurse Doctors make mistakes and this machine is just one more check.
..all in all he was a great talker..
On the way out dgei... grabbed Mr. Jerry Blair and we introduced ourselves as shareholders...he talked about being in an industry that he Loved and that he has been given opportunities to be with great companies
..and... he WAS in the development/beginning stages of Web MD...I asked..
dgei??..Correct me if I'm wrong what was it when he started with Cerner there were 120/150 employees and when he left there were how many...2000 + or more???...I think he loves the excitement of developing..I know if you love what you do you do it well...
Well...all in all...I only learned a little bit.. but I still thought it was exciting to take a look at the "beginning" of a company that acts like it's gonna be around a long long time....
I hope that I have wet "some" of your whistles...This bunch is a hard bunch to appease...lol..
Some info on bashers http://www.messageboardfool.com/bashers.htm
Don't know...unless maybe a handful of old LOCH investors lurking out there....
Woof
can someone tell me what the story is on the Britts wanting to bash cdex?
Some links from a European News Service
http://www.in-pharmatechnologist.com/
http://www.in-pharmatechnologist.com/news/ng.asp?n=64330-baxa-cdex-valimed
Welcome aboard. Yes you can post links, post away.
Thanks for letting me join, Viking and Matt, Looks like a good board.Are we allowed to post links?
My pleasure. Thanks for your great DD. Please feel free to post here.
Coming to YOUR OR soon??? Karen
http://allnurses.com/forums/f16/utah-health-sciences-center-addresses-narcotics-diversion-or-new-ana....
ValiMed system meets JCAHO and ASHP Standards by validating return of controlled substances from the operating room.
Narcotic drug diversion is a long-standing problem for healthcare organizations. Many studies find that between five and 10 percent of anesthesiologists, nurses, and pharmacists have used this class of medications illegally. By substituting saline or water, narcotics-abusing clinicians had an undetectable source of drugs that compromised patient safety.
At the University of Utah Health Sciences Center, the University of Utah Hospital is one of the first hospitals in the country to tackle the problem at the source. Using ValiMed, a new device from CDEX, the hospital now validates the contents of all returned narcotics from the operating room.
“ValiMed pretty much eliminates a major source of narcotic drug diversion,” said Jim Jorgenson, Director of Pharmacy Services, and Associate Dean for Clinical Affairs, University of Utah College of Pharmacy. “Its spectral analysis ensures every returned syringe contains narcotics and not just water. The machine is the size of a shoebox and fits in our satellite pharmacy; any pharmacy technician can perform the validation in seconds.”
Full press release:http://www.valimed.com/media_center/pr/012605.htm
From another board
BAXA's PR about the Pharmacists Meeting Dec.5-8.
Baxa to Launch ValiMed Medication Validation System at ASHP Midyear Meeting
Baxa Corporation announces its launch of the ValiMed System for medication safety at booth no. 2221 at the American Society of Health-System Pharmacists Midyear Meeting to be held December 4 8, 2005 in Las Vegas, Nev. The innovative ValiMed Technology offers validation of medication to ensure the type and strength of high-risk medications. The technology also validates narcotic returns and identifies counterfeit medications.
Englewood, Colo., November 29, 2005 Baxa Corporation will introduce the ValiMed Medication Validation System at the 40th annual meeting of the American Society for Health-System Pharmacists. Over the course of the five-day meeting, Baxa representatives will demonstrate the new technology, designed to validate medication type and strength; detect counterfeit products for brand protection, and provide quality assurance for compounded products.
The ValiMed System offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patent-pending technology identifies the strength to validate compounded doses of high risk medications prior to dispensing. The ValiMed Device verifies medications in seconds, providing an added level of safety in the medication dispensing process. The system also assists with detection of narcotic loss and identification of counterfeit medications.
The ValiMed Solution fits with Baxa Corporation's mission to offer our customers innovative fluid medication devices that improve operations and increase medication safety, said Greg Baldwin, Baxa Chairman and CEO. ValiMed is a great addition to our product lines, he notes of the announcement.
At the meeting, Baxa representatives will be demonstrating the ValiMed Systems capabilities in their booth, number 2221. CDEX Inc., developer of the ValiMed Medication Validation System and other innovative substance detection and verification systems, is participating in the meeting as well in booth number 1021. Representatives of CDEX Inc. will be demonstrating the ValiMed Systems ability to distinguish authentic flu vaccines and Tamiflu.
The ValiMed System is ideally suited to address modern hospital pharmacy needs, said Malcolm Philips, CDEX CEO and Chairman. The technology allows pharmacists to ensure the accuracy of compounded solutions, meeting USP 797 and other regulatory requirements. The ASHP launch spotlights the ValiMed technology for meeting medication accuracy and med error reduction goals.
Capabilities of the ValiMed Medication Validation System will be spotlighted in two poster sessions during the meeting: Improving medication safety: use of spectral medication validation in high risk intravenous medication (IV) compounding in a pediatric hospital pharmacy, based on experiences at the University of Michigans CS Mott Childrens Hospital (Monday, December 5, 2005; 2:00 PM) and Use of spectroscopy to enhance safety in IV compounding, James G. Stevenson PharmD, Director of Pharmacy Services, University of Michigan Health System (Wednesday, December 7, 2005; 3:00 PM).
For more than 30 years, Baxa Corporation has focused on developing systems and devices that streamline pharmacy operations, enhancing patient
I believe this tells it all on where we are headed.
From the latest PR.
In a process that takes only seconds, ValiMed uses patent pending technology to validate compounded doses of high-risk medications prior to dispensing. The solution creates an added level of safety in the medication dispensing process, and is also used to validate narcotic returns as well as identify counterfeit medications.
"We are focused on patient safety at UMMC, and the CDEX ValiMed product offers us an additional opportunity to validate the end products being dispensed from the pharmacy and to validate returned narcotics," said Marc Summerfield, Director of Pharmacy at UMMC. "With ValiMed, we will have an added level of safety on certain products that we dispense every day, and added cost-effective audit capabilities for our controlled substances compliance initiatives."
University of Maryland Medical Center Partners with CDEX to Implement Medication Validation Solution; CDEX's ValiMed System Chosen by UMMS to Verify Compounded Medications and Doses, Validate Narcotic Returns, and Identify Counterfeit Pharmaceuticals
11/29/2005 10:00:08 AM
ROCKVILLE, Md. & BALTIMORE, Nov 29, 2005 (BUSINESS WIRE) -- The University of Maryland Medical Center has selected the CDEX (CEXI) ValiMed system to perform end product testing of compounded intravenous medications in its pharmacy departments, and validation of returned narcotics in its operating room suites and nursing units. The CDEX ValiMed medication verification system was developed to give clinicians a quick, cost effective, and simple tool to further ensure medication safety by verifying medications are correctly compounded. The University of Maryland Medical Center (UMMC) is part of a private, not-for-profit organization that includes six hospitals and has more than 11,000 employees. The system provides a full range of primary and specialty care to people throughout Maryland and the Mid-Atlantic region. ValiMed will be installed at the University of Maryland Medical Center, a 655-bed teaching hospital.
In a process that takes only seconds, ValiMed uses patent pending technology to validate compounded doses of high-risk medications prior to dispensing. The solution creates an added level of safety in the medication dispensing process, and is also used to validate narcotic returns as well as identify counterfeit medications.
"We are focused on patient safety at UMMC, and the CDEX ValiMed product offers us an additional opportunity to validate the end products being dispensed from the pharmacy and to validate returned narcotics," said Marc Summerfield, Director of Pharmacy at UMMC. "With ValiMed, we will have an added level of safety on certain products that we dispense every day, and added cost-effective audit capabilities for our controlled substances compliance initiatives."
"As the list of nationally-recognized healthcare providers using the ValiMed solution continues to grow, CDEX is particularly pleased that the University of Maryland Medical Center, a world-class hospital located in the same region where CDEX is headquartered, has selected this innovative, proven system for end-product medication testing and return narcotic validation," said Malcolm Philips, CEO and Chairman of the Board for CDEX.
The CDEX ValiMed solution uses light energy and a library of unique spectral fingerprints to validate drugs in solution. The device validates that the correct drugs in the correct amounts have been added to the dose during the compounding process.
About The University of Maryland Medical Center (UMMC)
For more information, visit www.umm.edu.
About CDEX, Inc.
CDEX Inc. is a technology development company with a current focus
on developing and marketing products using chemical detection and
validation technologies. At present, CDEX is devoting its resources to
two distinct areas: (i) identification of substances of concern (e.g.,
explosives and illegal drugs for homeland security); and (ii)
validation of substances for anti-counterfeiting, brand protection and
quality assurance (e.g., validation of prescription medication and
detection of counterfeit or sub-par products for brand protection).
ValiMed is one line of CDEX products for the healthcare market. CDEX
is headquartered in Rockville, Maryland with its research and
development laboratory in Tucson, Arizona. For more information, visit
www.cdex-inc.com and www.valimed.com or contact Jim Griffin or Jerry
Blair at 301-881-0080 (cdexmanagement@cdex-inc.com).
Any statements made in this press release which contain information that is not historical are essentially forward-looking. Many forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks are detailed from time-to-time in filings with the Securities and Exchange Commission. There is no obligation to publicly update any forward-looking statements.
SOURCE: CDEX, Inc.
CDEX, Inc.
Brad Wills, 301-346-7398
bwills@wills-pr.com
Baxa to Launch ValiMed Medication Validation System at ASHP Midyear Meeting
http://www.prweb.com/releases/2005/11/prweb315205.htm
Baxa Corporation announces its launch of the ValiMed System for medication safety at booth no. 2221 at the American Society of Health-System Pharmacists Midyear Meeting to be held December 4 – 8, 2005 in Las Vegas, Nev. The innovative ValiMed Technology offers validation of medication to ensure the type and strength of high-risk medications. The technology also validates narcotic returns and identifies counterfeit medications.
Englewood, Colo., November 29, 2005 – Baxa Corporation will introduce the ValiMed Medication Validation System at the 40th annual meeting of the American Society for Health-System Pharmacists. Over the course of the five-day meeting, Baxa representatives will demonstrate the new technology, designed to validate medication type and strength; detect counterfeit products for brand protection, and provide quality assurance for compounded products.
The ValiMed System offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patent-pending technology identifies the strength to validate compounded doses of high risk medications prior to dispensing. The ValiMed Device verifies medications in seconds, providing an added level of safety in the medication dispensing process. The system also assists with detection of narcotic loss and identification of counterfeit medications.
“The ValiMed Solution fits with Baxa Corporation's mission to offer our customers innovative fluid medication devices that improve operations and increase medication safety,” said Greg Baldwin, Baxa Chairman and CEO. “ValiMed is a great addition to our product lines,” he notes of the announcement.
At the meeting, Baxa representatives will be demonstrating the ValiMed System’s capabilities in their booth, number 2221. CDEX Inc., developer of the ValiMed Medication Validation System and other innovative substance detection and verification systems, is participating in the meeting as well in booth number 1021. Representatives of CDEX Inc. will be demonstrating the ValiMed System’s ability to distinguish authentic flu vaccines and Tamiflu®.
“The ValiMed System is ideally suited to address modern hospital pharmacy needs,” said Malcolm Philips, CDEX CEO and Chairman. “The technology allows pharmacists to ensure the accuracy of compounded solutions, meeting USP 797 and other regulatory requirements.” The ASHP launch spotlights the ValiMed technology for meeting medication accuracy and med error reduction goals.
Capabilities of the ValiMed Medication Validation System will be spotlighted in two poster sessions during the meeting: Improving medication safety: use of spectral medication validation in high risk intravenous medication (IV) compounding in a pediatric hospital pharmacy, based on experiences at the University of Michigan’s CS Mott Children’s Hospital (Monday, December 5, 2005; 2:00 PM) and Use of spectroscopy to enhance safety in IV compounding, James G. Stevenson PharmD, Director of Pharmacy Services, University of Michigan Health System (Wednesday, December 7, 2005; 3:00 PM).
For more than 30 years, Baxa Corporation has focused on developing systems and devices that streamline pharmacy operations, enhancing patient safety and improving efficiency. Under an agreement announced in early November, Baxa is the exclusive distributor of the CDEX ValiMed System for healthcare organizations in the United States and Canada.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternative-site pharmacies. Privately held, Baxa Corporation has subsidiaries and offices in Canada, the United Kingdom and Denmark, and distribution partners worldwide. Further information is available at http://www.baxa.com.
About CDEX, Inc.
CDEX Inc. (OTCBB: CEXI), is a technology development company focused on developing and marketing products using chemical detection and validation technologies. CDEX technology is focused currently on two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance. CDEX is headquartered in Rockville, Maryland, with a primary research and development laboratory in Tucson, Arizona. For more information, visit http://www.cdex-inc.com and http://www.valimed.com.
Contacts:
For Baxa Corporation
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
For CDEX
Brad Wills
Wills PR: 301.346.7398
Any statements in this release that are not historical are essentially forward-looking. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Baxa Corporation and CDEX Inc. undertake no obligation to publicly update any forward-looking statements.
###
This press release was posted by the following PR Firm
Absolutely Public Relations (View Listing in Directory of PR Firms)
CDEXs PR Agency Wills and Associates has MedChi as a client, and MedChi recognizes that medical errors are a significant problem in the health care delivery system. To that end, MedChi has been actively involved in various patient safety initiatives in the State and an active participant in the effort to continue to find creative and effective means to reduce medical errors. MedChi represents over 7,200 Maryland physicians and their patients.
http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051128005...
http://www.medchi.org/Gvmt_Affairs/2004legaction/HB0433.pdf
The Maryland State Medical Society (MedChi) which represents over 7,200 Maryland physicians and their patients opposes House Bill
http://www.medchi.org/convention/MedChi_inside%20and%20form-FINAL.pdf
http://www.medchi.org/
http://www.wills-pr.com/clients.html
The Maryland State Medical Society: Grassroots Initiative for Medical Malpractice Liability Reform
http://www.medchi.org/archive_gvmt_affairs/2003legaction/legislative_initiatives.asp
MedChi will fight to assure that medical errors are reduced and patients are protected from substandard practice and that physicians are treated fairly.
http://www.medchi.org/aboutmedchi/index.asp
About MedChi (pronounced med-kī)
CDEX, Inc. Names Wills & Associates, Inc. as Public Relations Agency of Record
11/28/2005 12:31:01 PM
http://www.marketwatch.com/tools/quotes/newsarticle.asp?guid={7D5B62CD-587E-425C-9967-675DCB90C9E3}&....
ROCKVILLE, Md., Nov 28, 2005 (BUSINESS WIRE) -- CDEX, Inc. (www.cdex-inc.com), the Rockville, Md.-based developer of chemical substance verification and detection solutions used by the healthcare, brand protection, homeland security and law enforcement sectors, has named Wills Associates (www.wills-pr.com) as the company's public relations agency of record. Wills & Associates, with offices in Baltimore and Bethesda, Maryland, specializes in providing public relations services to technology businesses.
REPOST from SILICON INVESTOR board
To: the_seventh_guest(MOROVAN) who wrote (91) 11/16/2005 5:33:53 PM
From: INET6 of 92
Funinthesun: Elmo has banned me from his board . It seems with all his preaching he can not stand the truth.
As per ELMO I don't know where you have been for 8 years ,but since he clued you in, I'LL STRAIGHTEN YOU OUT!!
He says most of the Loch Harris people are still with CDEX .
Well in my opinion they have certainly learned their lesson.
We knew,even elmo knew that Loch harris was selling shares with no intention of progressing with a product.LH fed us all kinds of great news and reports, and we complain that CDEX tell us only what we need to hear. There is certainly a difference there
NOW IMHO IT seems that the scientists knew they had a potential and why they ever signed on with Loch I will never know.
Poteet made a reputation for himself long before he got hooked up with LH.
MP made a reputation for himself long before he got hooked up with LH .Sure he praised the technology,and managed to move into a position to get it away from them. Could be he praised it so much he fooled himself.LOL ,when he discovered it was not as good as he was preaching.
They started with ValiMed,since nothing else was near ready enough for the finances on hand.
Now no one sitting at a computer desk 15 hours a day bashing a company ,does nothing but make himself look like a jac3333,when he says CDEX has followed the same pattern that LH did.
HE ,You nor I have one iota of aclue as to what transpired to bring ValiMed to the market.
Yes,many thousands are still victims of the LH fiasco. I am one You probably are one. But the light may be at the end of the tunnel ,thanks to the efforts of Malcolm ,Poteet,and the rest of the CDEX crew.
For that matter didn't Morovan brag several weeks ago that he got out in time and managed to make money on his sale.
His 113 shares are a gift from the court,And he can't even consider that as a payout to just go away.
I sincerely hope CROW ,even though we don't see eye to eye will allow controversy on his board.
NO sensible person that has been around four years ,are still making comparisons to LH,other than in the pocketbook, and hopefully that is going to change.,IN SPITE OF MOROVAN.
WOW.What a speech
CDEX INC. (OTCBB: CEXI)
http://www.watervilleresearch.com/
CDEX is a technology development company that is currently focused on developing/marketing products from its chemical detection and validation technologies (five patents pending). The emerging product lines identify/validate substances in environments that are difficult to monitor. CDEX is developing products across several market areas including: Homeland Security and Defense Sectors (e.g., detection of explosives); Healthcare and Medical Products (e.g., validation of chemo drugs).
LATEST CDEX NEWS...
http://www.cdex-inc.com/
• CDEX to Demonstrate Validation of Flu Vaccine and Flu Medications at The American Society of Health Systems Pharmacists (ASHP) MidYear Clinical Meeting December 4-8 - 11/14/05
• CDEX and Baxa Sign Distribution Agreement - 11/10/05
• BAXA and CDEX Announce Strategic Alignment - 11/2/05
• Medication Errors in the U.S. - WHOI-TV - 10/20/05
• CDEX’s ValiMed Unit Selected to Validate Controlled Substance Returns - 10/13/05
• Maricopa Medical Center Selects CDEX’s ValiMed Technology for End Product Testing - 10/12/05
• CDEX Announces Implementation and Acceptance of its ValiMed Patient Safety Solution - 9/29/05
• CDEX Announces New Chief Operating Officer - 9/19/05
• Blueprint for implementing USP chapter 797 for compounding sterile preparations
• U-M Health System is first in world to use new light-based system to check high-risk medicines - 7/05/05
In addition to demonstrations at the CDEX booth, the ValiMed solution will be highlighted at the following presentations at ASHP:
Presentation: Wednesday, 12/7/2005, 3:00 p.m. Use of Spectroscopy to Enhance Safety in IV Compounding, James G. Stevenson, Pharm.D., Director of Pharmacy Services, University of Michigan Health System, Ann Arbor
http://www.cdex-inc.com/pr/111405.html
................................................................
About James G. Stevenson
http://sitemaker.umich.edu/jimsteve
Associate Dean and Professor
Department of Clinical Sciences, College of Pharmacy
Director, Department of Pharmacy Services
University of Michigan Health Systems
University of Michigan, Ann Arbor, Michigan
· Pharm.D., Wayne State University, College of Pharmacy and Allied Health Professions, Detroit, Michigan
· B.S. in Pharmacy, Wayne State University, College of Pharmacy and Allied Health Professions, Detroit, Michigan
· Pre-Pharmacy, Michigan State University, East Lansing, Michigan
RESEARCH/PRACTICE INTERESTS
Health-system pharmacy administration, pharmacoeconomics, and outcomes research.
RECENT PUBLICATIONS
Ellis JJ, Erickson SR, Stevenson JG, Berstein SJ, Stiles RA, Fendrick AM. Sub-optimal statin compliance in primary and secondary prevention populations: should we target patients with the most to gain? (manuscript submitted to Journal of General Internal Medicine)
Ellis JJ, Stevenson JG. Decision Analysis: A Case Study. In Pharmacoeconomics and Outcomes: Applications for Patient Care, Second Edition. Edited by Dennis Grauer, Jeff Lee, Tanner Odom, Jane Osterhaus, Lisa Sanchez, and Dan Touchette, American College of Clinical Pharmacy (in press).
McCreadie SR, Stevenson JG, Sweet BV, Kramer M. Using personal digital assistants as a novel approach to accessing drug information. Am J Health-Syst Pharm 2002;59:1340-3.
Stevenson JG. Managing up: a key to effective leadership. Am J Health-Syst Pharm 2001;58(Suppl 1):S4-6.
Sweet BV, Stevenson JG. Pharmacy costs associated with processing non-formulary drug requests in an inpatient setting. Am J Health-Syst Pharm 2001; 58:1746-52.
McCreadie SR, Stevenson JG. Use of an intranet to improve communication and manage knowledge within a large, multi-site pharmacy department. Am J Health-Syst Pharm 2000; 57:1430-6.
Viking why did you remove my post 17,where I gave you permission to delete my previous post?
I believe I also made reference to Elmo threatening a court case, and asked someone, somewhere,somehow to please impress upon nim how absolutely stupid his 4 years of complaints were, since no one else including the courts paid any attention to them.
Why is it that wherever lmorovan posts, there are posts being deleted? There are arguements? There is name calling? There are always problems? Seems odd that when he doesn't post or isn't posting, the boards are very civil. Looks like Onthedge has called a spade a spade, and was right. Don't forget to whine and complain.
I request that you be removed from posting and especially being a moderator. Quit ruining this board with arguementitive posts! You get the responces you have earned.
Viking, I request that the last post by INET be removed. It is offensive and involves members of my family in a derogatory manner. If you are a fair moderator, you will comply.
INET6, LOL, man, you lost me there. I thought it was you and a few others that have threatened to take me to the court. Or implied that CDEX will do so. I am just waiting for anyone to honor their words and act upon their threats.
That is a fine speech,bnut why the post to Edge on the other IHub.
Including this threat.
But I will make a deal with you: let's leave the past confrontations for the time when we will have to present them before a court.
Better give it some thought!
Thanks for the note. At some point in time, there will be accountability for statements made. Right now the company is focused on other things. Thanks again.
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
516
|
Created
|
05/17/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |